Research TopicsSpecies | HUA E YUSummaryAffiliation: City of Hope National Medical Center Country: USA Publications
Research Grants
| Collaborators |
Detail Information
Publications
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironmentHua Yu
Division of Cancer Immunotherapeutics and Tumour Immunology, Beckman Research Institute at the City of Hope National Medical Center, Duarte, California 91010, USA
Nat Rev Immunol 7:41-51. 2007..Consequently, STAT3 has emerged as a promising target for cancer immunotherapy...
STATs in cancer inflammation and immunity: a leading role for STAT3Hua Yu
Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, California 91010, USA
Nat Rev Cancer 9:798-809. 2009..Consequently, STAT3 is a promising target to redirect inflammation for cancer therapy...
Research Grants
- Role of Stat3 in modulating tumor microenvironnment and angiogenesisHUA E YU; Fiscal Year: 2010..With these and other biological systems and reagents, the proposed studies will define whether Stat3 is an effective target for modulating tumor microenvironment and inhibiting angiogenesis. ..
- Role of Stat3 in tumor immune evasion and immune suppressionHua Yu; Fiscal Year: 2007..If our hypothesis is correct, inhibiting Stat3 in these subsets of immune cells will disrupt the immune suppressive networks, thereby enhancing the efficacy of DC and T-cell based immunotherapies. ..
- Role of Stat3 in modulating tumor microenvironment and angiogenesisHua Yu; Fiscal Year: 2007..With these and other biological systems and reagents, the proposed studies will define whether Stat3 is an effective target for modulating tumor microenvironment and inhibiting angiogenesis. ..
- Role of Stat3 in modulating tumor microenvironment and angiogenesisHua Yu; Fiscal Year: 2009..With these and other biological systems and reagents, the proposed studies will define whether Stat3 is an effective target for modulating tumor microenvironment and inhibiting angiogenesis. ..
- Role of Stat3 in tumor immune evasion and immune suppressionHUA E YU; Fiscal Year: 2010..If our hypothesis is correct, inhibiting Stat3 in these subsets of immune cells will disrupt the immune suppressive networks, thereby enhancing the efficacy of DC and T-cell based immunotherapies. ..
- Targeting Stat3 to Improve ImmunotherapyHUA E YU; Fiscal Year: 2010....
- Stat3 and anti-VEGF therapy in cancerHua Yu; Fiscal Year: 2007..Collectively, these studies may lead to development of more potent VEGF inhibitors for cancer therapy. ..
- Immune Responses in Cancer TherapyHua Yu; Fiscal Year: 2005..Finally, we will define the cellular and molecular mechanisms by which innate immune responses triggered by tumor-released pro-inflammatory factors impact on tumor-specific adaptive immune responses. ..
